British American Tobacco PLC
17 March 2006
DIRECTOR/PDMR SHAREHOLDING
The independent trustee of the British American Tobacco Group Employee Trust
notified the Company on 17 March 2006 that between 15 and 16 March 2006 it had
purchased 1,540,000 British American Tobacco p.l.c. 25p ordinary shares (the
"Shares") at a price of 1443.1266p per Share to satisfy the future release of
awards under the Company's long term incentive plan and deferred share bonus
scheme.
Following these transactions, the independent trustee of the British American
Tobacco Group Employee Trust holds a total of 23,282,556 Shares.
The following executive directors, together with other employees, are potential
beneficiaries under the trust, and are therefore deemed to be technically
interested for Companies Act purposes but were not connected with the
transaction that took place on the above mentioned dates: Mr P N Adams, Mr P A
Rayner and Mr A Monteiro de Castro.
A C Girling
Deputy Secretary
0207 845 1919
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.